Clinical Trial Update: Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism [Phase 2]

View source ↗

Summary

This Clinical Trial Update reports the termination of a Phase 2 study evaluating MEDI6012 on apolipoprotein B-100 metabolism, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• MEDI6012

Snippet

Sponsor: Columbia University | Conditions: Cardiovascular Diseases | Phase 2 | Status: TERMINATED | Results posted: 2024-11-12